Phase I and Phase IB Clinical Trials for the Noninvasive Evaluation of Intestinal Lactase With 4-Galactosylxylose (Gaxilose)
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 47 (6) , 501-508
Abstract
Goals and Background: Hypolactasia is widespread, yet reliable diagnostic tests are lacking. A new test based on oral administration of 4-galactosylxylose (gaxilose) and urine or serum measurement of d-xylose after cleavage by intestinal lactase is under clinical development. We investigated the optimal dose of gaxilose and calculate cutoff values of d-xylose for that dose. Study: In the randomized, dose-finding, phase I study, urine and serum pharmacokinetics of d-xylose were determined after oral administration of 6 ascending doses of gaxilose (and placebo) to 12 healthy adult volunteers. In the open, parallel, phase Ib study, 30 volunteers received the doses established for the urine and blood tests and d-xylose was measured. Cutoff values were calculated as 1.96xSD below the mean value. Safety was assessed through reporting of adverse events. Results: Gaxilose administration showed a progressive, dose-dependent increase in d-xylose in urine and serum. An optimal gaxilose dose of 0.45 g and urine collection periods of 4 and 5 hours were selected for further studies. For the blood test, a 2.7 g dose was selected and C-max measured at 90 minutes. The calculated cutoff values of d-xylose for normal lactase activity were 27.58 and 37.87 mg for the 4- and 5-hour urine tests, respectively, and 0.97 mg/dL for the blood test. There were no treatment-related adverse events. Conclusions: The methodology described provides a simple, safe test for the evaluation of lactase activity in vivo. Further evaluation of the test as a noninvasive diagnosis of hypolactasia is ongoing in patients with lactose intolerance.Keywords
This publication has 25 references indexed in Scilit:
- Subjective Perception of Lactose Intolerance Does Not Always Indicate Lactose MalabsorptionClinical Gastroenterology and Hepatology, 2010
- Molecular genetics of human lactase deficienciesAnnals of Medicine, 2009
- Introducing Genetic Testing for Adult-Type HypolactasiaDigestion, 2005
- Lactose (mal)digestion evaluated by the 13C‐lactose digestion testEuropean Journal of Clinical Investigation, 2000
- Variations in Colonic H2and CO2Production As a Cause of Inadequate Diagnosis of Carbohydrate Maldigestion in Breath TestsScandinavian Journal of Gastroenterology, 2000
- Non-Invasive Detection of Low-Intestinal Lactase Activity in Children by Use of a Combined13CO2/H2Breath TestScandinavian Journal of Gastroenterology, 1999
- Lactose digestion by human jejunal biopsies: the relationship between hydrolysis and absorption.Gut, 1986
- Reinvestigation of lactose intolerant children: lack of correlation between continuing lactose intolerance and small intestinal morphology, disaccharidase activity, and lactose tolerance tests.Gut, 1977
- Prospective Comparison of Indirect Methods for Detecting Lactase DeficiencyNew England Journal of Medicine, 1975
- BREATH HYDROGEN AS A DIAGNOSTIC METHOD FOR HYPOLACTASIAThe Lancet, 1975